| 1998-04-01 |
Founded KUMAMOTO Antibody Research Institute Inc. in Egoshi, Kumamoto City, with capital of 11 million yen, for the development, manufacturing, and sale of antibody reagents for protein function analysis. |
| 1998-04-21 |
On April 21, 1998, established Kumamoto Antibody Laboratory Inc. with capital of 11 million yen in Egoshi, Kumamoto City, for the purpose of developing, manufacturing, and selling antibodies as reagents for protein function analysis. |
| 1998-04-21 |
Established: April 21, 1998. |
| 1998-04-21 |
Established: April 21, 1998. |
| 2000-04 |
In April 2000, opened Tokyo Sales Office (Tokyo Office). Relocated headquarters to Kuhonji, Kumamoto City. Transferred the rights to the “Gene Trap Method Using Trap Vectors” from the Kumamoto Techno Poliss Foundation (now Public Interest Incorporated Foundation Kumamoto Industry Support Foundation), and started the gene knockout mouse business, changing the company name to Transgenic Inc. |
| 2000-04-01 |
Opened Tokyo Sales Office (Tokyo Office). Moved headquarters to Kyuhoji, Kumamoto City. |
| 2000-04 |
Opened Tokyo Sales Office (Tokyo Office). |
| 2000-04 |
Relocated headquarters to Kuhonji, Kumamoto City. |
| 2000-04 |
Received transfer of 'Gene Trap Vector and Gene Trap Method Using It' from Kumamoto Techno Poliss Foundation (now Public Interest Incorporated Foundation Kumamoto Industry Support Foundation), and started gene knockout mouse business, changing the trade name to Transgenic Corporation. |
| 2000-08 |
In August 2000, relocated headquarters to Chuo Street, Kumamoto City. |
| 2000-08-01 |
Moved headquarters to Chuo Street, Kumamoto City. |
| 2000-08 |
Relocated headquarters to Chuo Street, Kumamoto City. |
| 2001-12 |
In December 2001, signed a sales agreement for gene knockout mouse sequence information with Yakult Honsha Co., Ltd. (now Astellas Pharma Inc.) and Sumitomo Chemical Co., Ltd. |
| 2001-12-01 |
Entered into a sales agreement for gene knockout mouse sequence information with Yamauchi Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.). |
| 2001-12-01 |
Entered into a sales agreement for gene knockout mouse sequence information with Sumitomo Chemical Co., Ltd. (now Sumitomo Chemical Co., Ltd.). |
| 2001-12 |
Entered into a sales agreement for gene knockout mouse sequence information with Yamanochi Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.). |
| 2001-12 |
Entered into a sales agreement for gene knockout mouse sequence information with Sumitomo Chemical Co., Ltd. (now Sumitomo Chemical Co., Ltd.). |
| 2002-12 |
In December 2002, listed on the Mothers Market of the Tokyo Stock Exchange. |
| 2002-12-01 |
Listed on the Tokyo Stock Exchange Mothers Market. |
| 2002-12 |
Listed on Tokyo Stock Exchange Mothers Market. |
| 2003-06 |
In June 2003, relocated headquarters to Masaki Town, Kamimashiki District, Kumamoto Prefecture. |
| 2003-06-01 |
Moved headquarters to Mashiki Town, Kamimashiki District, Kumamoto Prefecture. |
| 2003-06 |
Relocated headquarters to Masaki Town, Kamimashiki District, Kumamoto Prefecture. |
| 2005-07 |
In July 2005, established Kobe Research Institute. |
| 2005-07-01 |
Established the Kobe Research Institute. |
| 2005-07 |
Established Kobe Research Institute. |
| 2006-02 |
In February 2006, relocated headquarters to Minami Kumamoto, Kumamoto City. |
| 2006-02-01 |
Relocated headquarters to Minami Kumamoto, Kumamoto City. |
| 2006-02 |
Relocated headquarters to Minami Kumamoto, Kumamoto City. |
| 2006-05 |
In May 2006, acquired shares of Primeum Corporation (now a consolidated subsidiary) and made it a subsidiary. |
| 2006-05-01 |
Acquired shares to make Primeum Corporation (now a consolidated subsidiary) a subsidiary. |
| 2006-05 |
Made PrimeUnion Co., Ltd. (now a consolidated subsidiary) a subsidiary through share acquisition. |
| 2012-12 |
In December 2012, relocated headquarters to Chuo Ward, Kumamoto City. |
| 2012-12-01 |
Relocated headquarters to Chuo Ward, Kumamoto City. |
| 2012-12 |
Relocated headquarters to Chuo Ward, Kumamoto City. |
| 2013-04 |
In April 2013, established Shinyaku Research Center Inc. (now a consolidated subsidiary). Transferred business from Shinyaku Development Laboratory to Shinyaku Research Center Inc. |
| 2013-04-01 |
Established New Drug Research Center Corporation (now a consolidated subsidiary). Transferred business from New Drug Development Laboratory Corporation. |
| 2013-04 |
Established Shin-Yaku Research Center Co., Ltd. (now a consolidated subsidiary). |
| 2013-04 |
Transferred business from Shin-Yaku Development Research Institute to Shin-Yaku Research Center Co., Ltd. |
| 2013-07 |
In July 2013, acquired shares of Medifom Inc. (now a consolidated subsidiary) and made it a subsidiary. Made Genetic Lab Inc. (now a consolidated subsidiary) a subsidiary through third-party allotment of shares. |
| 2013-07-01 |
Acquired shares to make Medifom Corporation (now a consolidated subsidiary) a subsidiary. |
| 2013-07-01 |
Made Genetic Lab Corporation (now a consolidated subsidiary) a subsidiary through third-party allotment of new shares. |
| 2013-07 |
Acquired shares of Medifom Inc. (currently a consolidated subsidiary) to make it a subsidiary. |
| 2013-07 |
Made Genetic Laboratory Inc. (currently a consolidated subsidiary) a subsidiary through third-party allotment of new shares. |
| 2015-07 |
In July 2015, made Medical Chemistry Drug Discovery Inc. (now a consolidated subsidiary) a related company through third-party allotment of shares. Moved headquarters to Chuo Ward, Fukuoka City. |
| 2015-07-01 |
Made Pharmaceutical Chemistry Drug Discovery Corporation (now a consolidated subsidiary) a related company through third-party allotment of new shares. |
| 2015-07-01 |
Relocated headquarters to Chuo Ward, Fukuoka City. |
| 2015-07 |
Made Medical Chemistry Drug Discovery Inc. (currently a consolidated subsidiary) an affiliated company through third-party allotment of new shares. |
| 2015-07 |
Relocated headquarters to Chuo Ward, Fukuoka City. |
| 2017-11 |
In November 2017, established TG Business Service Inc. (now a consolidated subsidiary). Acquired shares of Lopexx Japan Inc. (now a consolidated subsidiary) and made it a subsidiary. |
| 2017-11-01 |
Established TG Business Service Corporation (now a consolidated subsidiary). |
| 2017-11-01 |
Acquired shares to make Loupex Japan Corporation (now a consolidated subsidiary) a subsidiary. |
| 2017-11 |
Established TG Business Service Inc. (currently a consolidated subsidiary). |
| 2017-11 |
Made Lupex Japan Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition. |
| 2018-02 |
In February 2018, acquired shares of Outlet Plaza Inc. (now a consolidated subsidiary) and made it a subsidiary. |
| 2018-02-01 |
Acquired shares to make Outlet Plaza Corporation (now a consolidated subsidiary) a subsidiary. |
| 2018-02 |
Made Outlet Plaza Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition. |
| 2018-03 |
March 2018: Established Anpo Center Inc. (now a consolidated subsidiary). |
| 2018-03-01 |
Established Yasuhyo Center Corporation. |
| 2018-03 |
Established Yasuhyo Center Inc. (currently a consolidated subsidiary). |
| 2018-04 |
April 2018: Acquired business from Food, Agriculture, Medical and Pharmaceutical Safety Evaluation Center, a public interest incorporated foundation, at Anpo Center Inc. |
| 2018-04-01 |
Transferred business from the Food, Agriculture, Medical and Pharmaceutical Safety Evaluation Center, a public interest incorporated foundation, to Yasuhyo Center Corporation. |
| 2018-04 |
Transferred business from the Food, Agriculture, Medical, and Pharmaceutical Safety Evaluation Center, a public interest incorporated foundation, to Yasuhyo Center Inc. |
| 2019-04 |
April 2019: Made TGM Inc. (now a consolidated subsidiary) a subsidiary through share acquisition. |
| 2019-04-01 |
Acquired shares to make TGM Corporation (now a consolidated subsidiary) a subsidiary. |
| 2019-04 |
Made TGM Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition. |
| 2020-03 |
March 2020: Made Galax Trade Inc. (now a consolidated subsidiary) a subsidiary through share acquisition. |
| 2020-03-01 |
Acquired shares to make Galax Trade Corporation (now a consolidated subsidiary) a subsidiary. |
| 2020-03 |
Made Garlax Trading Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition. |
| 2021-04 |
April 2021: Transitioned to a pure holding company structure. |
| 2021-04-01 |
Transitioned to a pure holding company structure. |
| 2021-04 |
Transitioned to a pure holding company structure. |
| 2021-08-13 |
Explanation materials regarding business plan and growth potential |
| 2022-01 |
January 2022: Transferred all shares of Genetick Lab Inc. to Eurofins Clinical Testing Japan Holding Inc. |
| 2022-01-01 |
Transferred all shares of Genetic Lab Corporation to Eurofins Clinical Testing Japan Holding Corporation. |
| 2022-01 |
Transferred all shares of Genetic Laboratory Inc. to Eurofins Clinical Testing Japan Holding Inc. |
| 2022-04 |
April 2022: Changed from the Mothers Market to the Growth Market on the Tokyo Stock Exchange following a review of market classification. |
| 2022-04-01 |
Due to the review of market classification by the Tokyo Stock Exchange, transitioned from the Mothers Market to the Growth Market. |
| 2022-04 |
Changed from the Tokyo Stock Exchange Mothers Market to the Growth Market due to a review of market classification. |
| 2022-05-25 |
Explanation materials regarding business plan and growth potential |
| 2022-09 |
September 2022: Made Tomei Shokai Inc. (now a consolidated subsidiary) a subsidiary through share acquisition. |
| 2022-09-01 |
Acquired shares to make Tōmei Shōkai Corporation (now a consolidated subsidiary) a subsidiary. |
| 2022-09 |
Made Tomen Trading Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition. |
| 2023-01 |
January 2023: Excluded from subsidiaries following the transfer of all shares of Kizuki Inc. |
| 2023-01-01 |
Transferred all shares of Kizuki Corporation, excluding it from the subsidiary. |
| 2023-01 |
Excluded from subsidiaries by transferring all shares of Kizuki Inc. |
| 2023-03 |
March 2023: Made MASC Inc. (now a consolidated subsidiary) a subsidiary through share acquisition. |
| 2023-03-01 |
Made MAS Corporation (now a consolidated subsidiary) a subsidiary through share acquisition. |
| 2023-03 |
Made MASC Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition. |
| 2023-06-02 |
Explanation materials regarding business plan and growth potential |
| 2024-06 |
June 2024: Made Tohoku Shinkwa Chemical Inc. a subsidiary through share acquisition. |
| 2024-06-01 |
Made Tohoku Shinkwa Chemical Corporation a subsidiary through share acquisition. |
| 2024-06 |
Made Tohoku Shinwa Chemical Inc. a subsidiary through share acquisition. |
| 2024-06-03 |
Explanation materials regarding business plan and growth potential |
| 2024-10 |
October 2024: Merged New Drug Research Center Inc. and Anpo Center Inc. through absorption-type merger with New Drug Research Center Inc. as the surviving company, and changed the trade name to Transgenic Inc., then to Transgenic Group Inc. |
| 2024-10-01 |
Merged with Shin-Yaku Research Center Co., Ltd. and Shin-Yaku Center Co., Ltd. using an absorption-type merger with Shin-Yaku Research Center Co., Ltd. as the surviving company, and changed the trade name to Transgenic Corporation. Changed the trade name to Transgenic Group Corporation. |
| 2024-10 |
Merged Shinyaku Research Center Inc. and Yasuhyo Center Inc. by absorption-type merger with Shinyaku Research Center Inc. as the surviving company, and changed the trade name to Transgenic Inc. |
| 2024-10 |
Changed the trade name to Transgenic Group Inc. |
| 2025-06-25 |
Matters regarding business plan and growth potential |
| 2026-02-01 |
Changed market to Tokyo Stock Exchange Standard Market. |
| 2026-02 |
Changed market to the Tokyo Stock Exchange Standard Market. |
